Skip to content
Multidisciplinary Association for Psychedelic Studies – MAPS

Multidisciplinary Association for Psychedelic Studies - MAPS

  • About
    • Our Mission
    • Our History
    • Our Team
    • Community Allies
  • Our Work
    • Advancing Research
    • Changing Policy
    • Evolving Education
    • The Virtual Trip
  • News
    • Updates
    • Newsletter
    • Press Releases
    • MAPS Bulletin
    • MAPS in the Media
    • Newsroom
  • Take Action
    • MAPS Membership
    • Donate
    • Volunteer
    • Careers
    • Community Events
    • Resources
    • Integration Station
    • Music Is the Bridge
  • Store
    • Learning
    • Apparel
    • Accessories
    • Bookshop
Login
  • Donate
0

News

MAPS PBC Adopts Charter for Independent Ethics Review Board

FOR IMMEDIATE RELEASE Independent members will inform continual iteration and improvement of ethical governance of MDMA-assisted therapy research and therapist training program Independent Ethical Review …
February 2, 2022

MAPS is Granted Innovation Passport in United Kingdom for MDMA as an Adjunct to Therapy for PTSD

FOR IMMEDIATE RELEASE MDMA as an adjunct to therapy for PTSD is the forty-first treatment to receive the Innovation Passport since its inception in January 2021 The designation is intended to accelerate …
January 25, 2022

Awakn Life Sciences and MAPS to Explore Partnership for Treatment of Alcohol Use Disorder in Europe

FOR IMMEDIATE RELEASE On January 19, 2022, the Multidisciplinary Association for Psychedelic Studies (MAPS) and its wholly owned drug-development subsidiary MAPS Public Benefit Corporation (MAPS PBC) entered …
January 19, 2022

Psyche Unbound, a collection of essays in honor of Stanislav Grof, to be released in January 2022

Psyche Unbound: Essays in Honor of Stanislav Grof is an extraordinary compilation of twenty-two essays that honor the path-breaking lifework of Stanislav Grof, M.D., Ph.D., the world’s leading researcher …
December 8, 2021

MAPS and Vine Ventures Pioneer Novel Regenerative Funding Structure to Infuse Psychedelic-Assisted Therapy Research and Access With Timely $70 Million

Revenue share payments will be based on North America sales of MDMA for use in MDMA-assisted therapy, will terminate after 8 years, and include a reciprocity payment structure that reduces payments once …
December 2, 2021

California State Senate Takes Step To Dismantle Psychedelic Prohibition

Fifty years after the War on Drugs was officially declared and psychedelic substance prohibition began in contravention of evidence supporting therapeutic use, the California State Senate has taken the …
June 23, 2021

Lawsuit Filed Against the DEA and Attorney General to Compel Issuance of Licenses to Manufacture Marijuana for Clinical Trials and Potential FDA Approval

On the heels of United Nations’ Commission on Narcotic Drugs removal of medical marijuana from the list of most dangerous drugs, lawsuit demands processing and approval of licenses to support research …
December 3, 2020

Lawsuit Filed Against the DEA and Attorney General to Compel Issuance of Licenses to Manufacture Marijuana for Clinical Trials and Potential FDA Approval

On the heels of United Nations’ Commission on Narcotic Drugs removal of medical marijuana from the list of most dangerous drugs, lawsuit demands processing and approval of licenses to support research …
December 3, 2020

DEA Eliminates 48-Year-Old Monopoly on Research-Grade Marijuana, Clearing Pathway for FDA Approval and Rescheduling

WASHINGTON, D.C. — Today, the Drug Enforcement Administration (DEA) announced their intention to grant licenses to additional marijuana growers for research, thereby ending the DEA-imposed 48-year monopoly …
August 11, 2016

Study Initiated Exploring MDMA-Assisted Therapy for Social Anxiety in Autistic Adults

Los Angeles Biomedical Research Institute and MAPS: Study Initiated Exploring MDMA-Assisted Therapy for Social Anxiety in Autistic Adults. Seeking new therapies for the treatment of social anxiety in autistic …
March 27, 2014

Would You Take MDMA for Therapy?

Vice William Alexander …
April 29, 2013

DEA Judge Recommends End to Government Obstruction of Medical Marijuana Research

Contact Jag Davies, MAPS Director of Communications (831) 336-4325 or jag@maps.org For Immediate Release February 13, 2007 DEA Judge Recommends End to Government Obstruction of Medical Marijuana Research …
February 14, 2007

Posts pagination

Newer Posts Page 1 … Page 4
Multidisciplinary Association for Psychedelic Studies – MAPS
  • About
    • Our Mission
    • Our History
    • Our Team
    • Financial Reports
    • Careers
    • Refunds & Returns
    • FAQs
    • Privacy Policy
    • Global Affiliates
  • Our Work
    • Psychedelic Fundamentals
    • The Virtual Trip
    • U.S. MDMA Therapy Education
    • Health Equity
    • Policy & Advocacy
  • Advancing Research
    • MDMA
    • Marijuana
    • LSD
    • Ibogaine
    • Ayahuasca
  • News
    • Updates
    • MAPS in the Media
    • MAPS Bulletin
    • MAPS Podcast
    • Monthly Newsletter
    • Press Releases
    • Newsroom
  • Take Action
    • MAPS Membership
    • Donate
    • Participate in a Trial
    • Events
    • Resources

Newsletter Sign Up

  • Facebook
  • Instagram
  • Twitter
  • YouTube
  • LinkedIn
  • Reddit
© 1986 - 2026 Multidisciplinary Association for Psychedelic Studies. All Rights Reserved. Disclaimer | Privacy Policy.
3141 Stevens Creek Blvd #40563, San Jose, CA 95117.
Mail checks to: MAPS P.O. Box 103004 Pasadena, CA 91189-3004.
Proudly powered by WordPress. Hosted by Pressable.

Download our Integration Guide

Just enter your email in order to download our Integration Guide